Global Tourism Forum Annual Meeting 2022 Indonesia Aligns with the G20 Spirit to Recover Together, Recover Stronger – “Time for Travel & Tourism” (TTT)
London, United Kingdom–(Newsfile Corp. – September 22, 2022) – In the stream of the G20…
Year: 2022
Hitachi Energy launches innovative oil-free and plug-and-play traction transformer
ZURICH, SWITZERLAND, Sep 22, 2022 – (JCN Newswire) – Hitachi Energy today announced the launch…
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
HONG KONG, Sep 22, 2022 – (ACN Newswire) – Agilis Robotics Limited (“Agilis Robotics” or…
Starflex-VR Launches K-Pop 3D VR Platform “SFVR”
SEOUL, KOREA, Sept 22, 2022 – (ACN Newswire) – Starflex-VR Inc. has launched a K-pop…
Orange and Netskope Partner on Carrier-class Connectivity and SSE Services for a Secure, Cloud-smart Platform
Provides greater security and flexibility to Orange customers Unleashes unparalleled service coverage, performance, and resilience…
Future of Digital Trust Explored at Upcoming ISACA Conference Europe Featuring Opening Keynote Hannah Fry
SCHAUMBURG, Ill.–(BUSINESS WIRE)–#isaca–Bringing together global industry experts and thought leaders, ISACA Conference Europe, 19-21 October…
CUTRA Co., Ltd. Launches High Performing Ultrasonic Cutter “CtrlAX”
CUTRA Co., Ltd., a fast-growing manufacturing company specializing in high technology launches CtrlAX, an innovative…
Restricted Shares Will be Lifted on 22 September, and the Management and Investors of Arrail Group are “Hoarding”, Release High Growth Signals
HONG KONG, Sep 22, 2022 – (ACN Newswire) – The restricted shares of Arrail Group…
Retail SaaS major Unicommerce eyes to double its transaction volumes in Southeast Asia
Singapore, Sep 22, 2022 – (ACN Newswire) – Unicommerce, an integrated SaaS platform for post-purchase…
Cloudflare Launches Data Localization Suite in Asia to Help Customers Achieve Data Sovereignty
Customers in Australia, India, and Japan can now service traffic locally while benefiting from Cloudflare’s…
UK-Based Canterbury Christ Church University Deploys YuJa Himalayas for Enterprise Archiving to Serve Three Locations with a Digital Compliance and Archival Solution
SAN JOSE, Calif.–(BUSINESS WIRE)–United Kingdom-based Canterbury Christ Church University, a long-standing customer of YuJa, Inc.,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GrafTech International Ltd. (EAF) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial
Montrouge, France, September 21, 2022 DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial…
The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form of ALS
Publication includes the Phase 3 VALOR SOD1-ALS trial and its open-label-extension study, underscoring the importance…
Medicenna Announces Results of Annual Meeting of Shareholders
TORONTO and HOUSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the…
Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
Sino Biopharm a leading Chinese pharmaceutical group, through CTTQ will oversee the development and commercialization…
Krystal Biotech Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for B-VEC for the treatment of Dystrophic Epidermolysis Bullosa
• Company on track to submit European marketing application in Q4 2022 • No additional…
Kinnate Biopharma Inc. Receives Fast Track Designation from the U.S. Food and Drug Administration for KIN-2787, an Investigational Pan-RAF Inhibitor
SAN FRANCISCO and SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Windtree to Present at the Ladenburg Thalmann Healthcare Conference
WARRINGTON, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…